ALZA Corporation is a pharmaceutical company founded in 1968 by Dr. Alejandro Zaffaroni. In May 2001, ALZA was acquired by Johnson & Johnson in a stock-for-stock transaction worth 10.5 billion dollars.
ALZA has developed and marketed many successful drug delivery platforms including: